Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Selective Bladder-Sparing Approach
Authors:
- 1 October 2014
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 90 (2) , 303-311
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Selective bladder preservation with curative intent for muscle‐invasive bladder cancer: A contemporary reviewInternational Journal of Urology, 2012
- ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder CancerPLOS ONE, 2011
- Targeting the dynamic HSP90 complex in cancerNature Reviews Cancer, 2010
- Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low‐dose chemo‐radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single‐institutional retrospective comparative studyBJU International, 2009
- Impact of HER2 Gene and Protein Status on the Treatment Outcome of Cisplatin-Based Chemoradiotherapy for Locally Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI)Cancer, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003
- Overview of bladder cancer trials in the Radiation Therapy Oncology GroupCancer, 2003
- HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implicationsInternational Journal of Cancer, 2002